After vaccination or infection, long-lived germinal centers can produce antibodies with high affinity and specificity against pathogens. In this issue of Cell, de Carvalho et al. and Hägglöf et al. show that naive B cells can invade germinal centers, replacing B cells that entered early and changing features of antibody production. These findings have implications for vaccine design.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cell.2022.12.023 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!